New products, campaigns to boost Sun Pharma OTC sales
After tying up with Nykaa, pharma major plans to sell products online03-10-2016
03-10-2016
Revital H Woman launches 'Healthy Conversations' initiative to bring the health of Indian women in focus
Sun Pharmaceutical Industries Ltd has informed BSE regarding a Press Release dated October 03, 2016 titled "Revital H Woman launches 'Healthy Conversations' initiative to bring the health of Indian women in focus".03-10-2016
Sun Pharma to Announce Late-Breaking Results for Investigational IL-23p19 inhibitor, Tildrakizumab, Achieves Primary End Point in Both Phase-3 Studies in Patients with Moderate-to-Severe Plaque Psoriasis
Sun Pharmaceutical Industries Ltd has informed BSE regarding a Press Release dated October 01, 2016 titled "Sun Pharma to Announce Late-Breaking Results for Investigational IL-23p19 inhibitor, Tildrakizumab, Achieves Primary End Point in Both Phase-3 Studies in Patients with Moderate-to-Severe Plaque Psoriasis".01-10-2016
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Raksha S Valia has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE29-09-2016
Sun Pharma sales staff on strike over pending wages
Over 500 Sun Pharma sales representatives are on a day's strike over release of the illegally deducted wages and recategorization of sales executives26-09-2016
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Raksha S Valia has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE23-09-2016
Submission of new set of Articles of Association of the Company
Sun Pharmaceutical Industries Ltd has informed BSE regarding "Submission of new set of Articles of Association of the Company".22-09-2016
Sun Pharma: all eyes on buyback
Shares of Sun Pharmaceuticals will remain in focus, as the 675-crore buyback offer opens on Thursday. The company offers 900 a share to mop up 75 lakh shares from shareholders whose name appeared21-09-2016
Speech delivered at AGM
Sun Pharmaceutical Industries Ltd has submitted to BSE a copy of a Speech delivered at 24th Annual General Meeting held on September 17, 2016.19-09-2016
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Sun Pharmaceutical Industries Ltd has informed BSE regarding the details of Voting results at the 24th Annual General Meeting (AGM) of the Company held on September 17, 2016, under Regulation 44(3) of SEBI (LODR) Regulations, 2015.19-09-2016